Endocrine News
VerifiedMagazine
Endocrine News is a monthly news and feature magazine published by the Endocrine Society as a benefit for members and other interested parties. The magazine provides an in-depth look at trends in the field of endocrinology as well as a closer look at recently published research. Additionally, the editorial content in Endocrine News provides its audience with helpful information, insight, and education about the field and practice of endocrinology and endocrine research.
Endocrine News informs and engages the global endocrine community by delivering timely, accurate, and trusted content covering the practice, research, and profession of endocrinology. Source
Actions
Media Outlet details
| Scope | National, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
Recent Articles
Search ArticlesStar Power 2026: Q&A with Dillon Boulton, PhD
Each year, one of the most popular events at ENDO is the Rising Stars Power Talks and ENDO 2026 was certainly no different. These talks see 15 early-career and in-training Endocrine Society members get the chance to communicate their groundbreaking research with an audience of their peers.
The Hidden Side Effect of Weight-Loss Surgery: Severe Low Blood Sugar
At least one in 12 weight-loss surgery patients develop a severe, recurring low blood sugar condition requiring medical intervention, according to a multi-study analysis presented at the ENDO 2026 conference. The condition, known as post-bariatric hypoglycemia (PBH), currently lacks any U.S. Food and Drug Administration-approved treatments.
Pharma Friday – August 14, 2026
On August 6, Ascendis Pharma A/S provided updates across its achondroplasia programs. “The rapid uptake of YUVIWEL in the United States underscores its highly differentiated profile and reflects our core values and our patient-centered development of therapies,” said Jan Mikkelsen, President and chief executive officer of Ascendis Pharma.
In Pursuit of Precision: New Lab Tech
In the lab, even the smallest variation can impact results, making precision essential at every step. As endocrinology research continues to expand, the tools supporting this work are evolving just as quickly. Today’s laboratories rely on technologies that not only deliver sensitivity and accuracy, but also streamline workflows and support reproducible, high-confidence results.
VIDEO: Clinical Trials Suggest GLP-1s May Improve fertility in Men with Obesity
GLP-1s may improve testosterone levels and sperm quality in men with obesity related low testosterone, according to an ENDO 2026 study by Pratibha Natesh, MBBS, MRCP, MRes. Natesh explains the key findings in more detail in our video series. Scientists at the University Hospitals Coventry and Warwickshire and Warwick Medical School in Coventry, United Kingdom, made the discovery after searching medical databases for published randomized controlled trials.
Compassionate Curiosity: Q&A with Martin Reincke, MD
For Martin Reincke, MD, the most important advances in endocrinology have never been about discoveries alone. They’ve always been about the people whose lives those discoveries can change. Whether it’s leading international collaborations to improve care for patients with adrenal disorders or mentoring the next generation of physician-scientists, Reincke has built a career on the belief that exceptional research and compassionate medicine go hand in hand.
Acromegaly Mortality Rates Drop Sharply Amid Better Tools and Personalized Care
Medical advances in diagnostic screening and personalized therapies have drastically reduced the early mortality risk for patients with acromegaly, bringing their life expectancy close to that of the general population, according to a comprehensive review titled “,” and recently published in The Journal of Clinical Endocrinology & Metabolism. The findings reveal a rapidly transforming landscape for the management of this rare endocrine condition.
Realizing the Promise: Artificial Intelligence in Endocrinology
At a packed session on Saturday, June 13th at ENDO 2026, two researchers who study artificial intelligence (AI) in healthcare set out to answer some of the many nagging questions related to the purported AI revolution in “Artificial Intelligence in Endocrinology: Practical Uses, Lessons Learned, and What Comes Next.” Says session chair Juan P.
Fall Meetings Offer World-Class Learning for Both Clinicians and Researchers
The outstanding ENDO 2026 in Chicago, Ill., is now but a fond memory. Our hardworking member volunteers and staff who organized and executed the meeting can take a well-deserved break. But only a short break. The Society already is busy preparing an exciting lineup of fall meetings that will appeal to both our researcher and clinician members. As a long-time member, I know firsthand the value of our Society meetings.
VIDEO: Testosterone Alone is Not a Replacement for Lifestyle Changes in Older Men at Risk of Type 2 Diabetes
Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes, but an ENDO 2026 study by Gary Wittert, MBBch, MD, finds these benefits require engagement in a lifestyle program. More than 40 million people in the U.S. and hundreds of millions worldwide have been diagnosed with type 2 diabetes, and more than 115 million adults in the U.S. are estimated to have prediabetes.